ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Follicular Lymphoma Treatment Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-9G6341
Home | Market Reports | Health| Health Conditions| Cancer
Global Follicular Lymphoma Treatment Market Insights Forecast to 2028
BUY CHAPTERS

Global Follicular Lymphoma Treatment Market Research Report 2025

Code: QYRE-Auto-9G6341
Report
January 2025
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Boehringer Ingelheim GmbH
Bristol Myers Squibb Company
Celgene Corporation
Celldex Therapeutics Inc
Celltrion
Cellular Biomedicine Group Inc
Coherus BioSciences Inc
CTI BioPharma Corp
Curis
Dynavax Technologies Corporation
Eisai Co Ltd
EpiZyme Inc
F Hoffmann La Roche Ltd
Genentech Inc
Gilead Sciences Inc
GlaxoSmithKline PLC
Hutchison MediPharma Limited
Immune Design Corp
ImmunoGen Inc

Follicular Lymphoma Treatment Market Size

The global market for Follicular Lymphoma Treatment was valued at US$ 1782 million in the year 2024 and is projected to reach a revised size of US$ 2275 million by 2031, growing at a CAGR of 3.6% during the forecast period.

Follicular Lymphoma Treatment Market

Follicular Lymphoma Treatment Market

Follicular lymphoma is a cancer that affects white blood cells called lymphocytes. There are two types of lymphomas: Hodgkin"s and non-Hodgkin"s, based on the kind of white blood cell they affect. Follicular lymphoma is a non-Hodgkin"s lymphoma.Drugs for Follicular lymphoma are Anti-CD20 mAbs, Chemotherapy Agents, Kinase Inhibitor, etc.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Follicular Lymphoma Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Follicular Lymphoma Treatment.
The Follicular Lymphoma Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Follicular Lymphoma Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Follicular Lymphoma Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Follicular Lymphoma Treatment Market Report

Report Metric Details
Report Name Follicular Lymphoma Treatment Market
Accounted market size in year US$ 1782 million
Forecasted market size in 2031 US$ 2275 million
CAGR 3.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Celgene Corporation, Celldex Therapeutics, Inc., Celltrion, Inc., Cellular Biomedicine Group, Inc., Coherus BioSciences, Inc., CTI BioPharma Corp., Curis, Inc., Dynavax Technologies Corporation, Eisai, EpiZyme, Inc., F. Hoffmann-La Roche Ltd., Genentech, Inc., Gilead Sciences, Inc., GlaxoSmithKline Plc, Hutchison MediPharma Limited, Immune Design Corp., ImmunoGen, Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Follicular Lymphoma Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Follicular Lymphoma Treatment Market growing?

Ans: The Follicular Lymphoma Treatment Market witnessing a CAGR of 3.6% during the forecast period 2025-2031.

What is the Follicular Lymphoma Treatment Market size in 2031?

Ans: The Follicular Lymphoma Treatment Market size in 2031 will be US$ 2275 million.

Who are the main players in the Follicular Lymphoma Treatment Market report?

Ans: The main players in the Follicular Lymphoma Treatment Market are Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Celgene Corporation, Celldex Therapeutics, Inc., Celltrion, Inc., Cellular Biomedicine Group, Inc., Coherus BioSciences, Inc., CTI BioPharma Corp., Curis, Inc., Dynavax Technologies Corporation, Eisai, EpiZyme, Inc., F. Hoffmann-La Roche Ltd., Genentech, Inc., Gilead Sciences, Inc., GlaxoSmithKline Plc, Hutchison MediPharma Limited, Immune Design Corp., ImmunoGen, Inc.

What are the Application segmentation covered in the Follicular Lymphoma Treatment Market report?

Ans: The Applications covered in the Follicular Lymphoma Treatment Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Follicular Lymphoma Treatment Market report?

Ans: The Types covered in the Follicular Lymphoma Treatment Market report are Chemotherapy, Radiotherapy, Monoclonal Antibodies, Stem Cell Transplantation

Recommended Reports

Lymphoma Treatment

Leukemia & Malignancy

Cancer Therapy Drugs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Follicular Lymphoma Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Chemotherapy
1.2.3 Radiotherapy
1.2.4 Monoclonal Antibodies
1.2.5 Stem Cell Transplantation
1.3 Market by Application
1.3.1 Global Follicular Lymphoma Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Follicular Lymphoma Treatment Market Perspective (2020-2031)
2.2 Global Follicular Lymphoma Treatment Growth Trends by Region
2.2.1 Global Follicular Lymphoma Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Follicular Lymphoma Treatment Historic Market Size by Region (2020-2025)
2.2.3 Follicular Lymphoma Treatment Forecasted Market Size by Region (2026-2031)
2.3 Follicular Lymphoma Treatment Market Dynamics
2.3.1 Follicular Lymphoma Treatment Industry Trends
2.3.2 Follicular Lymphoma Treatment Market Drivers
2.3.3 Follicular Lymphoma Treatment Market Challenges
2.3.4 Follicular Lymphoma Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Follicular Lymphoma Treatment Players by Revenue
3.1.1 Global Top Follicular Lymphoma Treatment Players by Revenue (2020-2025)
3.1.2 Global Follicular Lymphoma Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Follicular Lymphoma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Follicular Lymphoma Treatment Revenue
3.4 Global Follicular Lymphoma Treatment Market Concentration Ratio
3.4.1 Global Follicular Lymphoma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Follicular Lymphoma Treatment Revenue in 2024
3.5 Global Key Players of Follicular Lymphoma Treatment Head office and Area Served
3.6 Global Key Players of Follicular Lymphoma Treatment, Product and Application
3.7 Global Key Players of Follicular Lymphoma Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Follicular Lymphoma Treatment Breakdown Data by Type
4.1 Global Follicular Lymphoma Treatment Historic Market Size by Type (2020-2025)
4.2 Global Follicular Lymphoma Treatment Forecasted Market Size by Type (2026-2031)
5 Follicular Lymphoma Treatment Breakdown Data by Application
5.1 Global Follicular Lymphoma Treatment Historic Market Size by Application (2020-2025)
5.2 Global Follicular Lymphoma Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Follicular Lymphoma Treatment Market Size (2020-2031)
6.2 North America Follicular Lymphoma Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Follicular Lymphoma Treatment Market Size by Country (2020-2025)
6.4 North America Follicular Lymphoma Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Follicular Lymphoma Treatment Market Size (2020-2031)
7.2 Europe Follicular Lymphoma Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Follicular Lymphoma Treatment Market Size by Country (2020-2025)
7.4 Europe Follicular Lymphoma Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Follicular Lymphoma Treatment Market Size (2020-2031)
8.2 Asia-Pacific Follicular Lymphoma Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Follicular Lymphoma Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Follicular Lymphoma Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Follicular Lymphoma Treatment Market Size (2020-2031)
9.2 Latin America Follicular Lymphoma Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Follicular Lymphoma Treatment Market Size by Country (2020-2025)
9.4 Latin America Follicular Lymphoma Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Follicular Lymphoma Treatment Market Size (2020-2031)
10.2 Middle East & Africa Follicular Lymphoma Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Follicular Lymphoma Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Follicular Lymphoma Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boehringer Ingelheim GmbH
11.1.1 Boehringer Ingelheim GmbH Company Details
11.1.2 Boehringer Ingelheim GmbH Business Overview
11.1.3 Boehringer Ingelheim GmbH Follicular Lymphoma Treatment Introduction
11.1.4 Boehringer Ingelheim GmbH Revenue in Follicular Lymphoma Treatment Business (2020-2025)
11.1.5 Boehringer Ingelheim GmbH Recent Development
11.2 Bristol-Myers Squibb Company
11.2.1 Bristol-Myers Squibb Company Company Details
11.2.2 Bristol-Myers Squibb Company Business Overview
11.2.3 Bristol-Myers Squibb Company Follicular Lymphoma Treatment Introduction
11.2.4 Bristol-Myers Squibb Company Revenue in Follicular Lymphoma Treatment Business (2020-2025)
11.2.5 Bristol-Myers Squibb Company Recent Development
11.3 Celgene Corporation
11.3.1 Celgene Corporation Company Details
11.3.2 Celgene Corporation Business Overview
11.3.3 Celgene Corporation Follicular Lymphoma Treatment Introduction
11.3.4 Celgene Corporation Revenue in Follicular Lymphoma Treatment Business (2020-2025)
11.3.5 Celgene Corporation Recent Development
11.4 Celldex Therapeutics, Inc.
11.4.1 Celldex Therapeutics, Inc. Company Details
11.4.2 Celldex Therapeutics, Inc. Business Overview
11.4.3 Celldex Therapeutics, Inc. Follicular Lymphoma Treatment Introduction
11.4.4 Celldex Therapeutics, Inc. Revenue in Follicular Lymphoma Treatment Business (2020-2025)
11.4.5 Celldex Therapeutics, Inc. Recent Development
11.5 Celltrion, Inc.
11.5.1 Celltrion, Inc. Company Details
11.5.2 Celltrion, Inc. Business Overview
11.5.3 Celltrion, Inc. Follicular Lymphoma Treatment Introduction
11.5.4 Celltrion, Inc. Revenue in Follicular Lymphoma Treatment Business (2020-2025)
11.5.5 Celltrion, Inc. Recent Development
11.6 Cellular Biomedicine Group, Inc.
11.6.1 Cellular Biomedicine Group, Inc. Company Details
11.6.2 Cellular Biomedicine Group, Inc. Business Overview
11.6.3 Cellular Biomedicine Group, Inc. Follicular Lymphoma Treatment Introduction
11.6.4 Cellular Biomedicine Group, Inc. Revenue in Follicular Lymphoma Treatment Business (2020-2025)
11.6.5 Cellular Biomedicine Group, Inc. Recent Development
11.7 Coherus BioSciences, Inc.
11.7.1 Coherus BioSciences, Inc. Company Details
11.7.2 Coherus BioSciences, Inc. Business Overview
11.7.3 Coherus BioSciences, Inc. Follicular Lymphoma Treatment Introduction
11.7.4 Coherus BioSciences, Inc. Revenue in Follicular Lymphoma Treatment Business (2020-2025)
11.7.5 Coherus BioSciences, Inc. Recent Development
11.8 CTI BioPharma Corp.
11.8.1 CTI BioPharma Corp. Company Details
11.8.2 CTI BioPharma Corp. Business Overview
11.8.3 CTI BioPharma Corp. Follicular Lymphoma Treatment Introduction
11.8.4 CTI BioPharma Corp. Revenue in Follicular Lymphoma Treatment Business (2020-2025)
11.8.5 CTI BioPharma Corp. Recent Development
11.9 Curis, Inc.
11.9.1 Curis, Inc. Company Details
11.9.2 Curis, Inc. Business Overview
11.9.3 Curis, Inc. Follicular Lymphoma Treatment Introduction
11.9.4 Curis, Inc. Revenue in Follicular Lymphoma Treatment Business (2020-2025)
11.9.5 Curis, Inc. Recent Development
11.10 Dynavax Technologies Corporation
11.10.1 Dynavax Technologies Corporation Company Details
11.10.2 Dynavax Technologies Corporation Business Overview
11.10.3 Dynavax Technologies Corporation Follicular Lymphoma Treatment Introduction
11.10.4 Dynavax Technologies Corporation Revenue in Follicular Lymphoma Treatment Business (2020-2025)
11.10.5 Dynavax Technologies Corporation Recent Development
11.11 Eisai
11.11.1 Eisai Company Details
11.11.2 Eisai Business Overview
11.11.3 Eisai Follicular Lymphoma Treatment Introduction
11.11.4 Eisai Revenue in Follicular Lymphoma Treatment Business (2020-2025)
11.11.5 Eisai Recent Development
11.12 EpiZyme, Inc.
11.12.1 EpiZyme, Inc. Company Details
11.12.2 EpiZyme, Inc. Business Overview
11.12.3 EpiZyme, Inc. Follicular Lymphoma Treatment Introduction
11.12.4 EpiZyme, Inc. Revenue in Follicular Lymphoma Treatment Business (2020-2025)
11.12.5 EpiZyme, Inc. Recent Development
11.13 F. Hoffmann-La Roche Ltd.
11.13.1 F. Hoffmann-La Roche Ltd. Company Details
11.13.2 F. Hoffmann-La Roche Ltd. Business Overview
11.13.3 F. Hoffmann-La Roche Ltd. Follicular Lymphoma Treatment Introduction
11.13.4 F. Hoffmann-La Roche Ltd. Revenue in Follicular Lymphoma Treatment Business (2020-2025)
11.13.5 F. Hoffmann-La Roche Ltd. Recent Development
11.14 Genentech, Inc.
11.14.1 Genentech, Inc. Company Details
11.14.2 Genentech, Inc. Business Overview
11.14.3 Genentech, Inc. Follicular Lymphoma Treatment Introduction
11.14.4 Genentech, Inc. Revenue in Follicular Lymphoma Treatment Business (2020-2025)
11.14.5 Genentech, Inc. Recent Development
11.15 Gilead Sciences, Inc.
11.15.1 Gilead Sciences, Inc. Company Details
11.15.2 Gilead Sciences, Inc. Business Overview
11.15.3 Gilead Sciences, Inc. Follicular Lymphoma Treatment Introduction
11.15.4 Gilead Sciences, Inc. Revenue in Follicular Lymphoma Treatment Business (2020-2025)
11.15.5 Gilead Sciences, Inc. Recent Development
11.16 GlaxoSmithKline Plc
11.16.1 GlaxoSmithKline Plc Company Details
11.16.2 GlaxoSmithKline Plc Business Overview
11.16.3 GlaxoSmithKline Plc Follicular Lymphoma Treatment Introduction
11.16.4 GlaxoSmithKline Plc Revenue in Follicular Lymphoma Treatment Business (2020-2025)
11.16.5 GlaxoSmithKline Plc Recent Development
11.17 Hutchison MediPharma Limited
11.17.1 Hutchison MediPharma Limited Company Details
11.17.2 Hutchison MediPharma Limited Business Overview
11.17.3 Hutchison MediPharma Limited Follicular Lymphoma Treatment Introduction
11.17.4 Hutchison MediPharma Limited Revenue in Follicular Lymphoma Treatment Business (2020-2025)
11.17.5 Hutchison MediPharma Limited Recent Development
11.18 Immune Design Corp.
11.18.1 Immune Design Corp. Company Details
11.18.2 Immune Design Corp. Business Overview
11.18.3 Immune Design Corp. Follicular Lymphoma Treatment Introduction
11.18.4 Immune Design Corp. Revenue in Follicular Lymphoma Treatment Business (2020-2025)
11.18.5 Immune Design Corp. Recent Development
11.19 ImmunoGen, Inc.
11.19.1 ImmunoGen, Inc. Company Details
11.19.2 ImmunoGen, Inc. Business Overview
11.19.3 ImmunoGen, Inc. Follicular Lymphoma Treatment Introduction
11.19.4 ImmunoGen, Inc. Revenue in Follicular Lymphoma Treatment Business (2020-2025)
11.19.5 ImmunoGen, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Boehringer Ingelheim GmbH
Bristol Myers Squibb Company
Celgene Corporation
Celldex Therapeutics Inc
Celltrion
Cellular Biomedicine Group Inc
Coherus BioSciences Inc
CTI BioPharma Corp
Curis
Dynavax Technologies Corporation
Eisai Co Ltd
EpiZyme Inc
F Hoffmann La Roche Ltd
Genentech Inc
Gilead Sciences Inc
GlaxoSmithKline PLC
Hutchison MediPharma Limited
Immune Design Corp
ImmunoGen Inc
List of Tables
 Table 1. Global Follicular Lymphoma Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Chemotherapy
 Table 3. Key Players of Radiotherapy
 Table 4. Key Players of Monoclonal Antibodies
 Table 5. Key Players of Stem Cell Transplantation
 Table 6. Global Follicular Lymphoma Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Follicular Lymphoma Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Follicular Lymphoma Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Follicular Lymphoma Treatment Market Share by Region (2020-2025)
 Table 10. Global Follicular Lymphoma Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Follicular Lymphoma Treatment Market Share by Region (2026-2031)
 Table 12. Follicular Lymphoma Treatment Market Trends
 Table 13. Follicular Lymphoma Treatment Market Drivers
 Table 14. Follicular Lymphoma Treatment Market Challenges
 Table 15. Follicular Lymphoma Treatment Market Restraints
 Table 16. Global Follicular Lymphoma Treatment Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Follicular Lymphoma Treatment Market Share by Players (2020-2025)
 Table 18. Global Top Follicular Lymphoma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Follicular Lymphoma Treatment as of 2024)
 Table 19. Ranking of Global Top Follicular Lymphoma Treatment Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Follicular Lymphoma Treatment Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Follicular Lymphoma Treatment, Headquarters and Area Served
 Table 22. Global Key Players of Follicular Lymphoma Treatment, Product and Application
 Table 23. Global Key Players of Follicular Lymphoma Treatment, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Follicular Lymphoma Treatment Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Follicular Lymphoma Treatment Revenue Market Share by Type (2020-2025)
 Table 27. Global Follicular Lymphoma Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Follicular Lymphoma Treatment Revenue Market Share by Type (2026-2031)
 Table 29. Global Follicular Lymphoma Treatment Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Follicular Lymphoma Treatment Revenue Market Share by Application (2020-2025)
 Table 31. Global Follicular Lymphoma Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Follicular Lymphoma Treatment Revenue Market Share by Application (2026-2031)
 Table 33. North America Follicular Lymphoma Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Follicular Lymphoma Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Follicular Lymphoma Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Follicular Lymphoma Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Follicular Lymphoma Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Follicular Lymphoma Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Follicular Lymphoma Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Follicular Lymphoma Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Follicular Lymphoma Treatment Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Follicular Lymphoma Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Follicular Lymphoma Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Follicular Lymphoma Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Follicular Lymphoma Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Follicular Lymphoma Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Follicular Lymphoma Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Boehringer Ingelheim GmbH Company Details
 Table 49. Boehringer Ingelheim GmbH Business Overview
 Table 50. Boehringer Ingelheim GmbH Follicular Lymphoma Treatment Product
 Table 51. Boehringer Ingelheim GmbH Revenue in Follicular Lymphoma Treatment Business (2020-2025) & (US$ Million)
 Table 52. Boehringer Ingelheim GmbH Recent Development
 Table 53. Bristol-Myers Squibb Company Company Details
 Table 54. Bristol-Myers Squibb Company Business Overview
 Table 55. Bristol-Myers Squibb Company Follicular Lymphoma Treatment Product
 Table 56. Bristol-Myers Squibb Company Revenue in Follicular Lymphoma Treatment Business (2020-2025) & (US$ Million)
 Table 57. Bristol-Myers Squibb Company Recent Development
 Table 58. Celgene Corporation Company Details
 Table 59. Celgene Corporation Business Overview
 Table 60. Celgene Corporation Follicular Lymphoma Treatment Product
 Table 61. Celgene Corporation Revenue in Follicular Lymphoma Treatment Business (2020-2025) & (US$ Million)
 Table 62. Celgene Corporation Recent Development
 Table 63. Celldex Therapeutics, Inc. Company Details
 Table 64. Celldex Therapeutics, Inc. Business Overview
 Table 65. Celldex Therapeutics, Inc. Follicular Lymphoma Treatment Product
 Table 66. Celldex Therapeutics, Inc. Revenue in Follicular Lymphoma Treatment Business (2020-2025) & (US$ Million)
 Table 67. Celldex Therapeutics, Inc. Recent Development
 Table 68. Celltrion, Inc. Company Details
 Table 69. Celltrion, Inc. Business Overview
 Table 70. Celltrion, Inc. Follicular Lymphoma Treatment Product
 Table 71. Celltrion, Inc. Revenue in Follicular Lymphoma Treatment Business (2020-2025) & (US$ Million)
 Table 72. Celltrion, Inc. Recent Development
 Table 73. Cellular Biomedicine Group, Inc. Company Details
 Table 74. Cellular Biomedicine Group, Inc. Business Overview
 Table 75. Cellular Biomedicine Group, Inc. Follicular Lymphoma Treatment Product
 Table 76. Cellular Biomedicine Group, Inc. Revenue in Follicular Lymphoma Treatment Business (2020-2025) & (US$ Million)
 Table 77. Cellular Biomedicine Group, Inc. Recent Development
 Table 78. Coherus BioSciences, Inc. Company Details
 Table 79. Coherus BioSciences, Inc. Business Overview
 Table 80. Coherus BioSciences, Inc. Follicular Lymphoma Treatment Product
 Table 81. Coherus BioSciences, Inc. Revenue in Follicular Lymphoma Treatment Business (2020-2025) & (US$ Million)
 Table 82. Coherus BioSciences, Inc. Recent Development
 Table 83. CTI BioPharma Corp. Company Details
 Table 84. CTI BioPharma Corp. Business Overview
 Table 85. CTI BioPharma Corp. Follicular Lymphoma Treatment Product
 Table 86. CTI BioPharma Corp. Revenue in Follicular Lymphoma Treatment Business (2020-2025) & (US$ Million)
 Table 87. CTI BioPharma Corp. Recent Development
 Table 88. Curis, Inc. Company Details
 Table 89. Curis, Inc. Business Overview
 Table 90. Curis, Inc. Follicular Lymphoma Treatment Product
 Table 91. Curis, Inc. Revenue in Follicular Lymphoma Treatment Business (2020-2025) & (US$ Million)
 Table 92. Curis, Inc. Recent Development
 Table 93. Dynavax Technologies Corporation Company Details
 Table 94. Dynavax Technologies Corporation Business Overview
 Table 95. Dynavax Technologies Corporation Follicular Lymphoma Treatment Product
 Table 96. Dynavax Technologies Corporation Revenue in Follicular Lymphoma Treatment Business (2020-2025) & (US$ Million)
 Table 97. Dynavax Technologies Corporation Recent Development
 Table 98. Eisai Company Details
 Table 99. Eisai Business Overview
 Table 100. Eisai Follicular Lymphoma Treatment Product
 Table 101. Eisai Revenue in Follicular Lymphoma Treatment Business (2020-2025) & (US$ Million)
 Table 102. Eisai Recent Development
 Table 103. EpiZyme, Inc. Company Details
 Table 104. EpiZyme, Inc. Business Overview
 Table 105. EpiZyme, Inc. Follicular Lymphoma Treatment Product
 Table 106. EpiZyme, Inc. Revenue in Follicular Lymphoma Treatment Business (2020-2025) & (US$ Million)
 Table 107. EpiZyme, Inc. Recent Development
 Table 108. F. Hoffmann-La Roche Ltd. Company Details
 Table 109. F. Hoffmann-La Roche Ltd. Business Overview
 Table 110. F. Hoffmann-La Roche Ltd. Follicular Lymphoma Treatment Product
 Table 111. F. Hoffmann-La Roche Ltd. Revenue in Follicular Lymphoma Treatment Business (2020-2025) & (US$ Million)
 Table 112. F. Hoffmann-La Roche Ltd. Recent Development
 Table 113. Genentech, Inc. Company Details
 Table 114. Genentech, Inc. Business Overview
 Table 115. Genentech, Inc. Follicular Lymphoma Treatment Product
 Table 116. Genentech, Inc. Revenue in Follicular Lymphoma Treatment Business (2020-2025) & (US$ Million)
 Table 117. Genentech, Inc. Recent Development
 Table 118. Gilead Sciences, Inc. Company Details
 Table 119. Gilead Sciences, Inc. Business Overview
 Table 120. Gilead Sciences, Inc. Follicular Lymphoma Treatment Product
 Table 121. Gilead Sciences, Inc. Revenue in Follicular Lymphoma Treatment Business (2020-2025) & (US$ Million)
 Table 122. Gilead Sciences, Inc. Recent Development
 Table 123. GlaxoSmithKline Plc Company Details
 Table 124. GlaxoSmithKline Plc Business Overview
 Table 125. GlaxoSmithKline Plc Follicular Lymphoma Treatment Product
 Table 126. GlaxoSmithKline Plc Revenue in Follicular Lymphoma Treatment Business (2020-2025) & (US$ Million)
 Table 127. GlaxoSmithKline Plc Recent Development
 Table 128. Hutchison MediPharma Limited Company Details
 Table 129. Hutchison MediPharma Limited Business Overview
 Table 130. Hutchison MediPharma Limited Follicular Lymphoma Treatment Product
 Table 131. Hutchison MediPharma Limited Revenue in Follicular Lymphoma Treatment Business (2020-2025) & (US$ Million)
 Table 132. Hutchison MediPharma Limited Recent Development
 Table 133. Immune Design Corp. Company Details
 Table 134. Immune Design Corp. Business Overview
 Table 135. Immune Design Corp. Follicular Lymphoma Treatment Product
 Table 136. Immune Design Corp. Revenue in Follicular Lymphoma Treatment Business (2020-2025) & (US$ Million)
 Table 137. Immune Design Corp. Recent Development
 Table 138. ImmunoGen, Inc. Company Details
 Table 139. ImmunoGen, Inc. Business Overview
 Table 140. ImmunoGen, Inc. Follicular Lymphoma Treatment Product
 Table 141. ImmunoGen, Inc. Revenue in Follicular Lymphoma Treatment Business (2020-2025) & (US$ Million)
 Table 142. ImmunoGen, Inc. Recent Development
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Follicular Lymphoma Treatment Picture
 Figure 2. Global Follicular Lymphoma Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Follicular Lymphoma Treatment Market Share by Type: 2024 VS 2031
 Figure 4. Chemotherapy Features
 Figure 5. Radiotherapy Features
 Figure 6. Monoclonal Antibodies Features
 Figure 7. Stem Cell Transplantation Features
 Figure 8. Global Follicular Lymphoma Treatment Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Follicular Lymphoma Treatment Market Share by Application: 2024 VS 2031
 Figure 10. Hospital Case Studies
 Figure 11. Clinic Case Studies
 Figure 12. Others Case Studies
 Figure 13. Follicular Lymphoma Treatment Report Years Considered
 Figure 14. Global Follicular Lymphoma Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Follicular Lymphoma Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Follicular Lymphoma Treatment Market Share by Region: 2024 VS 2031
 Figure 17. Global Follicular Lymphoma Treatment Market Share by Players in 2024
 Figure 18. Global Top Follicular Lymphoma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Follicular Lymphoma Treatment as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Follicular Lymphoma Treatment Revenue in 2024
 Figure 20. North America Follicular Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Follicular Lymphoma Treatment Market Share by Country (2020-2031)
 Figure 22. United States Follicular Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Follicular Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Follicular Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Follicular Lymphoma Treatment Market Share by Country (2020-2031)
 Figure 26. Germany Follicular Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Follicular Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Follicular Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Follicular Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Follicular Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Follicular Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Follicular Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Follicular Lymphoma Treatment Market Share by Region (2020-2031)
 Figure 34. China Follicular Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Follicular Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Follicular Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Follicular Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Follicular Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Follicular Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Follicular Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Follicular Lymphoma Treatment Market Share by Country (2020-2031)
 Figure 42. Mexico Follicular Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Follicular Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Follicular Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Follicular Lymphoma Treatment Market Share by Country (2020-2031)
 Figure 46. Turkey Follicular Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Follicular Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Follicular Lymphoma Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Boehringer Ingelheim GmbH Revenue Growth Rate in Follicular Lymphoma Treatment Business (2020-2025)
 Figure 50. Bristol-Myers Squibb Company Revenue Growth Rate in Follicular Lymphoma Treatment Business (2020-2025)
 Figure 51. Celgene Corporation Revenue Growth Rate in Follicular Lymphoma Treatment Business (2020-2025)
 Figure 52. Celldex Therapeutics, Inc. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2020-2025)
 Figure 53. Celltrion, Inc. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2020-2025)
 Figure 54. Cellular Biomedicine Group, Inc. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2020-2025)
 Figure 55. Coherus BioSciences, Inc. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2020-2025)
 Figure 56. CTI BioPharma Corp. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2020-2025)
 Figure 57. Curis, Inc. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2020-2025)
 Figure 58. Dynavax Technologies Corporation Revenue Growth Rate in Follicular Lymphoma Treatment Business (2020-2025)
 Figure 59. Eisai Revenue Growth Rate in Follicular Lymphoma Treatment Business (2020-2025)
 Figure 60. EpiZyme, Inc. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2020-2025)
 Figure 61. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2020-2025)
 Figure 62. Genentech, Inc. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2020-2025)
 Figure 63. Gilead Sciences, Inc. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2020-2025)
 Figure 64. GlaxoSmithKline Plc Revenue Growth Rate in Follicular Lymphoma Treatment Business (2020-2025)
 Figure 65. Hutchison MediPharma Limited Revenue Growth Rate in Follicular Lymphoma Treatment Business (2020-2025)
 Figure 66. Immune Design Corp. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2020-2025)
 Figure 67. ImmunoGen, Inc. Revenue Growth Rate in Follicular Lymphoma Treatment Business (2020-2025)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Non Hodgkin s Lymphoma and Chronic Lymphoma Treatment Market Research Report 2024
Non Hodgkin Lymphoma Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
B Cell Non Hodgkin s Lymphoma Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Non Hodgkin s Lymphoma Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hodgkin s Lymphoma Drugs Market Research Report 2024
Global Blood Tumor Drugs Market Research Report 2024
Global Blood Tumor Treatment Market Research Report 2024
Lymphoblastic Lymphoma Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hematologic Malignancies Treatment Market Research Report 2024
Global Hematologic Oncology Treatment Market Research Report 2024
Global Anaplastic Large Cell Lymphoma Treatment Market Insights Forecast to 2030
Global Anaplastic Large Cell Lymphoma Drugs Market Insights Forecast to 2030
Global Hematological Cancers Market Research Report 2024
Global Chronic Lymphocytic Leukemia Drugs Market Research Report 2024
Global Follicular Lymphoma Drugs Market Research Report 2025
Global Blood Cancer Treatments Market Research Report 2024
Lymphoma Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Mantle Cell Lymphoma Therapeutics Market Insights Forecast to 2030
Global Chronic Lymphocytic Leukemia Treatment Market Research Report 2024
Global HIV related Lymphoma Drug Market Research Report 2024

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28I6901
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22R9736
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29A2598
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions